Quercetin and quercetin‐3‐<i><scp>O</scp></i>‐glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species‐associated inflammation

Abstract

The above-mentioned evidence indicates that quercetin and quercetin-3-O-glucuronide are equally effective in inhibiting ROS-associated inflammation and ameliorating insulin resistant endothelial dysfunction by beneficial regulation of IRS-1 function.